Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Medtronic plc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT – Research Report) and Molecular Part...

Analysts Are Bullish on These Healthcare Stocks: Medtronic (MDT), Molecular Partners (MOLN)

Electrolux AB ( ($SE:ELUX.B) ) just unveiled an announcement. Electrolux AB reported full-year 2025 results showing improved profitability despite ...

Electrolux boosts earnings and cash flow in 2025 but withholds dividend amid tariff and market headwinds

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Medtronic (MDT – Research Report), Outlook Therape...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Outlook Therapeutics (OTLK) and Johnson & Johnson (JNJ)

Bernstein analyst Lee Hambright maintained a Buy rating on Medtronic today and set a price target of $112.00. Hambright covers the Healthcare secto...

Bernstein Remains a Buy on Medtronic (MDT)

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic on January 7 and set a price target of $118.00. The company’s shares c...

RBC Capital Sticks to Its Buy Rating for Medtronic (MDT)

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Medtronic, with a price target of $116.00. According to TipRanks, ...

Barclays Sticks to Their Buy Rating for Medtronic (MDT)

If you want your portfolio to serve as a steady cash generator in 2026, dividend aristocrat stocks offer fertile ground for finding resilient incom...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MDT	$102.71	-0.24%	7.28M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MDT	$102.71	-0.2%	7.28M
3
4
5
6

MDT

MDT

No Data Available

Get Medtronic plc. Data in Excel

Get Medtronic plc. Data in Excel